Ketogenic diet: Stoking energy stores and still posing questions

Experimental Neurology

Volumn 211, Issue 1, 2008, Pages 11-13

  Knerr, Ina ^a,b   Pearl, Phillip L ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SUCCINATE SEMIALDEHYDE DEHYDROGENASE;

ARTICLE; ATAXIA; ELECTROCORTICOGRAPHY; ENZYME DEFICIENCY; EPILEPTIC STATE; HIPPOCAMPUS; HUMAN; KETOGENIC DIET; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL;

EID: 42749083108     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2008.01.015     Document Type: Note

References (20)

1. Berry-Kravis E. Booth G. Sanchez A.C. Woodbury-Kolb J. Carnitine levels and the ketogenic diet Epilepsia 42 2001 1445 1451
2. Bough K.J. Wetherington J. Hassel B. Pare J.F. Gawryluk J.W. Greene J.G. Shaw R. Smith Y. Geiger J.D. Dingledine R.J. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet Ann. Neurol. 60 2006 223 235
3. Brown A.J. Low-carb diets, fasting and euphoria: is there a link between ketosis and gamma-hydroxybutyrate (GHB)? Med. Hypotheses 68 2007 268 271
4. Cunnane S.C. Musa K. Ryan M.A. Whiting S. Fraser D.D. Potential role of polyunsaturates in seizure protection achieved with the ketogenic diet Prostaglandins Leukot. Essent. Fat. Acids 67 2002 131 135
5. Dahlin M. Elfving A. Ungerstedt U. Amark P. The ketogenic diet influences the levels of excitatory and inhibitory amino acids in the CSF in children with refractory epilepsy Epilepsy Res. 64 2005 115 125
6. Donarum E.A. Stephan D.A. Larkin K. Murphy E.J. Gupta M. Senephansiri H. Switzer R.C. Pearl P.L. Snead O.C. Jakobs C. Gibson K.M. Expression profiling reveals multiple myelin alterations in murine succinate semialdehyde dehydrogenase deficiency J. Inherit. Metab. Dis. 29 2006 143 156
7. Fraser D.D. Whiting S. Andrew R.D. Macdonald E.A. Musa-Veloso K. Cunnane S.C. Elevated polyunsaturated fatty acids in blood serum obtained from children on the ketogenic diet Neurology 60 2003 1026 1029
8. Gibson K.M. Gupta M. Senephansiri H. Jansen E.E.W. Montine T.J. Hyland K. Switzer R.C. Snead O.C. Jakobs C. Oxidant stress and neurodegeneration in murine succinic semialdehyde dehydrogenase (SSADH) deficiency G.F. Hoffmann Diseases of Neurotransmission 2006 SPS Publication Heilbronn 199 212
9. Gupta M. Greven R. Jansen E.E. Jakobs C. Hogema B.M. Froestl W. Snead O.C. Bartels H. Grompe M. Gibson K.M. Therapeutic intervention in mice deficient for succinate semialdehyde dehydrogenase (gamma-hydroxybutyric aciduria) J. Pharmacol. Exp. Ther. 302 2002 180 187
10. Hartman A.L. Gasior M. Vining E.P. Rogawski M.A. The neuropharmacology of the ketogenic diet Pediatr. Neurol. 36 2007 281 292
11. Hogema B.M. Gupta M. Senephansiri H. Burlingame T.G. Taylor M. Jakobs C. Schutgens R.B. Froestl W. Snead O.C. Diaz-Arrastia R. Bottiglieri T. Grompe M. Gibson K.M. Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase Nat. Genet. 29 2001 212 216
12. Klepper J. Engelbrecht V. Scheffer H. van der Knaap M.S. Fiedler A. GLUT1 deficiency with delayed myelination responding to ketogenic diet Pediatr. Neurol. 37 2007 130 133
13. Knerr I. Pearl P.L. Bottiglieri T. Snead O.C. Jakobs C. Gibson K.M. Therapeutic concepts in succinate semialdehyde dehydrogenase (SSADH; ALDH5a1) deficiency (gamma-hydroxybutyric aciduria). Hypotheses evolved from 25 years of patient evaluation, studies in Aldh5a1−/− mice and characterization of gamma-hydroxybutyric acid pharmacology J. Inherit. Metab. Dis. 30 2007 279 294
14. Maalouf M. Sullivan P.G. Davis L. Kim D.Y. Rho J.M. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation Neuroscience 145 2007 256 264
15. Nylen K. Velasquez J.L. Likhodii S.S. Cortez M.A. Shen L. Leshchenko Y. Adeli K. Gibson K.M. Burnham W.M. Snead O.C. III A ketogenic diet rescues the murine succinic semialdehyde dehydrogenase deficient phenotype Exp. Neurol. 210 2 2008 449 457
16. Pearl P.L. Gibson K.M. Acosta M.T. Vezina L.G. Theodore W.H. Rogawski M.A. Novotny E.J. Gropman A. Conry J.A. Berry G.T. Tuchman M. Clinical spectrum of succinic semialdehyde dehydrogenase deficiency Neurology 60 2003 1413 1417
17. Pearl P.L. Capp P.K. Novotny E.J. Gibson K.M. Inherited disorders of neurotransmitters in children and adults Clin. Biochem. 12 2005 1051 1058
18. Sauer S.W. Kölker S. Hoffmann G.F. Ten Brink H.J. Jakobs C. Gibson K.M. Okun J.G. Enzymatic and metabolic evidence for a region specific mitochondrial dysfunction in brains of murine succinic semialdehyde dehydrogenase deficiency ( Aldh5a1 −/− mice) Neurochem. Int. 50 2007 653 659
19. Thio L.L. Wong M. Yamada K.A. Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission Neurology 54 2000 325 331
20. Yudkoff M. Daikhin Y. Melo T.M. Nissim I. Sonnewald U. Nissim I. The ketogenic diet and brain metabolism of amino acids: relationship to the anticonvulsant effect Annu. Rev. Nutr. 27 2007 415 430